Premenstrual syndrome. Premenstrual tension syndrome
Conditions
Interventions
Intervention 1: Intervention group: Consume 1 pill 2000 IU vitamin D (Schiff
made in USA) every other day for 12 weeks. Intervention 2: Control group: Consume 1 pill placebo of vitamin D contained maltodextrin ("Roshd" Pharmaceutical Incubation Center of Tehran University of M
Treatment - Drugs
Placebo
Intervention group: Consume 1 pill 2000 IU vitamin D (Schiff
made in USA) every other day for 12 weeks
Control group: Consume 1 pill placebo of vitamin D contained maltodextrin ("Roshd" Pharmaceutical Incubation Center of Tehran University of Medical Sciences) every other day for 12 weeks
Sponsors
Vice Chancellor of Research, Iran University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 30 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Aged 18-30 years old; BMI 18.5-34.9 kg/m2; 25(OH) D<40 ng/ml; Normal menstrual cycle; Young girls having PMS according to PSST questionnaire. Exclusion criteria: Acute disease; Any event that effect on mental status; Migration.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity of premenstrual syndrome. Timepoint: Before and 12 weeks after intervention. Method of measurement: PSST Questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum 25(OH)-D3. Timepoint: Before and 12 weeks after intervention. Method of measurement: Laboratory Kit (EUROIMMUN; Germany). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Mohammad Reza Vafa
Iran University of Medical Sciences
Outcome results
None listed